According to the Wegovy prescribing information, it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Wegovy injection or Wegovy tablets
However, a recent study did not support this finding but rather attributed the increased risk of insulin resistance to the concomitant presence of metabolic dysfunctionassociated steatotic liver disease (MASLD) (81)
Spain Glutathione Resin Market, By Product Type2019-2030 (USD Million) 29
An Update On 73 US Obese Pediatric Patients Treated With Laparoscopic Adjustable Gastric Banding: Comorbidity Resolution And Compliance Continue reading [22] Kang, D.H., Kwon, S.H., Sim, W.Y., Lew, B.L., (2024)